B-Tg(mCdh17) MC38

• 321864

B-Tg(mCd70) MC38
B-Tg(mChil1) MC38

B-Tg(mCdh17) MC38

Product nameB-Tg(mCdh17) MC38
Catalog number321864
Strain backgroundC57BL/6
AliasesHPT-1; HPT-1/LI
TissueColon
DiseaseColon carcinoma
SpeciesMouse
ApplicationB-Tg(mCdh17) MC38 cells have the capability to establish tumors in vivo 

on this page

  • Description
  • Targeting strategy
  • Tumorigenicity
Description

The exogenous promoter and mouse Cdh17 coding sequence were inserted into the mouse genome randomly. Mouse Cdh17 is highly expressed on the surface of B-Tg(mCdh17) MC38 cells.
 

Targeting strategy

Gene targeting strategy for B-Tg(mCdh17) MC38 cells. The exogenous promoter and mouse Cdh17 coding sequence were inserted into the mouse genome randomly.

Tumor growth curve & Body weight changes

Subcutaneous homograft tumor growth of B-Tg(mCdh17) MC38 cells. B-Tg(mCdh17) MC38 cells (1x106) and wild-type MC38 cells (5x105) were subcutaneously implanted into C57BL/6N mice (female, 8-week-old, n=6). Tumor volume and body weight were measured twice a week. (A) Average tumor volume ± SEM. (B) Body weight (Mean ± SEM). Volume was expressed in mm3 using the formula: V=0.5 X long diameter X short diameter2. As shown in panel A, B-Tg(mCdh17) MC38 cells were able to establish tumors in vivo and can be used for efficacy studies.

Tumor growth curve of individual mice

B-Tg(mCdh17) MC38 tumor growth of individual mice. B-Tg(mCdh17) MC38 cells (1x106) and wild-type MC38 cells (5x105) were subcutaneously implanted into C57BL/6N mice (female, 8-week-old, n=6). As shown in panel, B-Tg(mCdh17) MC38 cells were able to establish tumors in vivo and can be used for efficacy studies.